$25.13
0.632.57%
At Close: -
$26.81
1.686.69%
After Hours: 6:31 PM EDT
15 minutes delayed
Comments
Loading...
Adient
ADNTNYSE
Adient (NYSE:ADNT) Stock, Analyst Ratings, Price Targets, Forecasts
Adient PLC has a consensus price target of $36 based on the ratings of 13 analysts. The high is $62 issued by Benchmark on August 7, 2023. The low is $26 issued by Exane BNP Paribas on July 1, 2024. The 3 most-recent analyst ratings were released by B of A Securities, JP Morgan, and Barclays on July 22, 2024, July 22, 2024, and July 16, 2024, respectively. With an average price target of $33.33 between B of A Securities, JP Morgan, and Barclays, there's an implied 24.33% upside for Adient PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
JP Morgan
Barclays
UBS
Exane BNP Paribas
1calculated from analyst ratings
Analyst Ratings for Adient
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 49.2% | B of A Securities | John Murphy | $42 → $40 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 15.63% | JP Morgan | Ryan Brinkman | $32 → $31 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 8.17% | Barclays | Dan Levy | $34 → $29 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 0.71% | UBS | Colin Langan | $31 → $27 | Maintains | Neutral | Get Alert |
| 07/01/2024 | Buy Now | -3.02% | Exane BNP Paribas | James Picariello | → $26 | Upgrade | Underperform → Neutral | Get Alert |
| 06/25/2024 | Buy Now | 19.36% | Wells Fargo | Colin Langan | $33 → $32 | Maintains | Overweight | Get Alert |
| 05/10/2024 | Buy Now | 19.36% | Morgan Stanley | Adam Jonas | $35 → $32 | Maintains | Underweight | Get Alert |
| 05/07/2024 | Buy Now | 19.36% | JP Morgan | Ryan Brinkman | $37 → $32 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | 26.82% | Barclays | Dan Levy | $37 → $34 | Maintains | Equal-Weight | Get Alert |
| 05/06/2024 | Buy Now | 11.9% | Deutsche Bank | Emmanuel Rosner | $32 → $30 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 23.09% | Wells Fargo | Colin Langan | $38 → $33 | Maintains | Overweight | Get Alert |
| 04/22/2024 | Buy Now | 38.01% | JP Morgan | Ryan Brinkman | $40 → $37 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | 38.01% | Barclays | Dan Levy | $41 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | 71.58% | B of A Securities | John Murphy | $50 → $46 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 49.2% | JP Morgan | Ryan Brinkman | $41 → $40 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 52.93% | Barclays | Dan Levy | $43 → $41 | Maintains | Overweight | Get Alert |
| 02/08/2024 | Buy Now | 49.2% | Wells Fargo | Colin Langan | $41 → $40 | Maintains | Overweight | Get Alert |
| 01/24/2024 | Buy Now | 60.39% | Barclays | Dan Levy | $47 → $43 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | 30.55% | Morgan Stanley | Adam Jonas | $38 → $35 | Maintains | Underweight | Get Alert |
| 11/10/2023 | Buy Now | 75.31% | Barclays | Dan Levy | $52 → $47 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 52.93% | Wells Fargo | Colin Langan | $49 → $41 | Maintains | Overweight | Get Alert |
| 10/13/2023 | Buy Now | 93.96% | Barclays | Dan Levy | $54 → $52 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | 49.2% | UBS | Colin Langan | $43 → $40 | Maintains | Neutral | Get Alert |
| 09/13/2023 | Buy Now | 60.39% | UBS | Colin Langan | → $43 | Initiates | → Neutral | Get Alert |
| 08/08/2023 | Buy Now | 41.74% | Morgan Stanley | Adam Jonas | $35 → $38 | Maintains | Underweight | Get Alert |
| 08/07/2023 | Buy Now | 131.26% | Benchmark | Michael Ward | $58 → $62 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 101.42% | Barclays | Dan Levy | $50 → $55 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 56.66% | JP Morgan | Ryan Brinkman | $38 → $42 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | 67.85% | Wells Fargo | Colin Langan | $48 → $45 | Maintains | Overweight | Get Alert |
| 06/01/2023 | Buy Now | — | Exane BNP Paribas | James Picariello | — | Downgrade | Neutral → Underperform | Get Alert |
| 05/04/2023 | Buy Now | 79.04% | Wells Fargo | Colin Langan | $49 → $48 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 86.5% | Barclays | Dan Levy | $54 → $50 | Maintains | Overweight | Get Alert |
| 04/17/2023 | Buy Now | 101.42% | Barclays | Dan Levy | $57 → $54 | Maintains | Overweight | Get Alert |
| 04/10/2023 | Buy Now | 82.77% | Wells Fargo | Colin Langan | $50 → $49 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | 112.61% | Barclays | Dan Levy | → $57 | Initiates | → Overweight | Get Alert |
| 02/09/2023 | Buy Now | 30.55% | Morgan Stanley | Adam Jonas | $29 → $35 | Maintains | Underweight | Get Alert |
| 02/09/2023 | Buy Now | — | Wolfe Research | Rod Lache | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 02/08/2023 | Buy Now | 86.5% | Wells Fargo | Colin Langan | $46 → $50 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 123.8% | Benchmark | Michael Ward | $48 → $60 | Maintains | Buy | Get Alert |
| 01/17/2023 | Buy Now | 71.58% | Wells Fargo | Colin Langan | $41 → $46 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | 93.96% | B of A Securities | John Murphy | $41 → $52 | Upgrade | Neutral → Buy | Get Alert |
| 11/28/2022 | Buy Now | 8.17% | Morgan Stanley | Adam Jonas | $27 → $29 | Maintains | Underweight | Get Alert |
| 11/08/2022 | Buy Now | 45.47% | Deutsche Bank | Emmanuel Rosner | → $39 | Downgrade | Buy → Hold | Get Alert |
| 11/07/2022 | Buy Now | 56.66% | Wells Fargo | Colin Langan | $37 → $42 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 34.28% | RBC Capital | Joseph Spak | → $36 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/09/2022 | Buy Now | 52.93% | B of A Securities | John Murphy | $48 → $41 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | 67.85% | Wells Fargo | Colin Langan | $41 → $45 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 0.71% | Morgan Stanley | Adam Jonas | $31 → $27 | Maintains | Underweight | Get Alert |
| 07/11/2022 | Buy Now | 52.93% | Wells Fargo | Colin Langan | $43 → $41 | Maintains | Overweight | Get Alert |
| 06/02/2022 | Buy Now | 15.63% | Morgan Stanley | Adam Jonas | $36 → $31 | Maintains | Underweight | Get Alert |
| 05/19/2022 | Buy Now | 86.5% | Credit Suisse | Dan Levy | $55 → $50 | Maintains | Outperform | Get Alert |
| 04/21/2022 | Buy Now | 52.93% | Deutsche Bank | Emmanuel Rosner | $59 → $41 | Maintains | Buy | Get Alert |
| 04/07/2022 | Buy Now | 38.01% | Barclays | Brian Johnson | $45 → $37 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | Buy Now | 34.28% | Morgan Stanley | Adam Jonas | $38 → $36 | Maintains | Underweight | Get Alert |
| 04/01/2022 | Buy Now | 86.5% | Wells Fargo | Colin Langan | $60 → $50 | Maintains | Overweight | Get Alert |
| 02/07/2022 | Buy Now | 123.8% | Wells Fargo | Colin Langan | $54 → $60 | Maintains | Overweight | Get Alert |
| 12/16/2021 | Buy Now | 60.39% | Barclays | Brian Johnson | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/11/2021 | Buy Now | 86.5% | Barclays | Brian Johnson | — | Maintains | Overweight | Get Alert |
| 10/11/2021 | Buy Now | 97.69% | Barclays | Brian Johnson | — | Maintains | Overweight | Get Alert |
| 09/10/2021 | Buy Now | 79.04% | Wells Fargo | Colin Langan | — | Maintains | Overweight | Get Alert |
| 08/10/2021 | Buy Now | 41.74% | Morgan Stanley | Adam Jonas | — | Maintains | Underweight | Get Alert |
| 08/09/2021 | Buy Now | 123.8% | Credit Suisse | Dan Levy | — | Maintains | Outperform | Get Alert |
| 08/06/2021 | Buy Now | 82.77% | RBC Capital | Joseph Spak | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Adient (ADNT) stock?
The latest price target for Adient (NYSE:ADNT) was reported by B of A Securities on July 22, 2024. The analyst firm set a price target for $40.00 expecting ADNT to rise to within 12 months (a possible 49.20% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Adient (ADNT)?
The latest analyst rating for Adient (NYSE:ADNT) was provided by B of A Securities, and Adient maintained their buy rating.
When was the last upgrade for Adient (ADNT)?
The last upgrade for Adient PLC happened on July 1, 2024 when Exane BNP Paribas raised their price target to $26. Exane BNP Paribas previously had an underperform for Adient PLC.
When was the last downgrade for Adient (ADNT)?
The last downgrade for Adient PLC happened on April 10, 2024 when Barclays changed their price target from $41 to $37 for Adient PLC.
When is the next analyst rating going to be posted or updated for Adient (ADNT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adient was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Adient (ADNT) correct?
While ratings are subjective and will change, the latest Adient (ADNT) rating was a maintained with a price target of $42.00 to $40.00. The current price Adient (ADNT) is trading at is $26.81, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.